½ÃÀ庸°í¼­
»óǰÄÚµå
1808926

¼¼°èÀÇ ½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå : ±¸¼º¿ä¼Òº°, ÃÖÁ¾ ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)

Digital Health For Cardiovascular Market, By Component, By End-use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: AnalystView Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® 311 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡´Â 426¾ï 2,429¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 22.50%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀåÀº ¸ð¹ÙÀÏ Çコ ¾Û, ¿þ¾î·¯ºí µð¹ÙÀ̽º, ¿ø°Ý ÀÇ·á, ¿ø°Ý ¸ð´ÏÅ͸µ Åø, ÀΰøÁö´É(AI), Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû µîÀÇ µðÁöÅÐ ±â¼úÀ» äÅÃÇÏ¿© ½ÉÇ÷°ü ÁúȯÀÇ ¿¹¹æ, Áø´Ü, ¸ð´ÏÅ͸µ, °ü¸®¸¦ ÇÏ´Â ÇコÄɾîÀÇ ÇÏÀ§ ÁýÇÕÀÔ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ȯÀÚ °á°ú¸¦ °³¼±Çϰí, ÀÓ»óÀû ÀÇ»ç°áÁ¤À» °­È­Çϰí, °Ç°­ °ü¸® ºñ¿ëÀ» ÁÙÀ̱â À§ÇØ ½Ç½Ã°£ µ¥ÀÌÅÍ ¼öÁý, ¿ø°Ý ȯÀÚ Âü¿©, °³º°È­µÈ ½ÉÇ÷°ü °ü¸®¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â ¼Ö·ç¼ÇÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀº °íÇ÷¾Ð, ºÎÁ¤¸Æ, ½ÉºÎÀü, °ü»óµ¿¸Æ Áúȯ µîÀÇ º´Å¸¦ ±â¼ú Áß½ÉÀÇ °³ÀÔÀ¸·Î Ä¡·áÇϵµ·Ï ¼³°èµÈ ±¤¹üÀ§ÇÑ Á¦Ç° ¹× ¼­ºñ½º¸¦ Æ÷ÇÔÇÕ´Ï´Ù.

½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå - ½ÃÀå ¿ªÇÐ

½ÉÇ÷°ü ÁúȯÀÇ ±ÞÁõÀº ½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼Ó

½ÉÇ÷°ü ÁúȯÀÇ ¼¼°èÀûÀÎ À¯º´·ü Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È ½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÉÇ÷°ü Áúȯ(CVD)Àº ½ÉÀå°ú Ç÷°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Áúº´ÀÔ´Ï´Ù. ½ÉÀåÀ̳ª Ç÷°ü¿¡ ÇØ¸¦ ³¢Ä¡´Â ÁúȯÀÇ ÃÑĪÀÔ´Ï´Ù. ½ÉÇ÷°ü µðÁöÅÐ ¼Ö·ç¼ÇÀº ȯÀÚ°¡ Áúº´ÀÇ À§Çè ¿äÀÎÀ» ÁÙÀÌ´Â °Ç°­ Ȱµ¿À» ÀÚü ¸ð´ÏÅ͸µÇϰí ÀÌ·¯ÇÑ ¶óÀÌÇÁ ½ºÅ¸ÀÏ º¯È­ÀÇ Áؼö¸¦ ÃËÁøÇÔÀ¸·Î½á ȯÀÚÀÇ ÀÚÀ²À» ÃËÁøÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀ» »ç¿ëÇÏ¸é ½ÉÇ÷°ü ÁúȯÀ¸·Î ÀÎÇÑ ÀÌȯÀ²°ú »ç¸Á·üÀÌ °¨¼ÒÇß½À´Ï´Ù. ±× °á°ú, ½ÉÇ÷°ü Áúȯ ȯÀÚ Áõ°¡°¡ ½ÉÇ÷°ü µðÁöÅÐ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 3¿ù ¿µ±¹ Á¤ºÎ ºÎ¹®ÀÎ Office for Health Improvement and Disparities°¡ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é, ¿µ±¹¿¡¼­ °ü»óµ¿¸Æ¼º ½ÉÀå ÁúȯÀÇ GP Áø´ÜÀ» ¹ÞÀº »ç¶÷Àº 186¸¸ 2,500¸í(3%)ÀÌ Á¶±Ý ³Ñ¾ú½À´Ï´Ù. ±× °á°ú, ½ÉÇ÷°ü ÁúȯÀÇ ¼¼°èÀûÀÎ À¯ÇàÀÌ ½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

½ÉÇ÷°ü µðÁöÅÐ Çコ ¼¼°è ½ÃÀåÀº ±¸¼º ¿ä¼Ò, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº ±¸¼º ¿ä¼Ò¿¡ µû¶ó ¼ÒÇÁÆ®¿þ¾î, ¼­ºñ½º ¹× Çϵå¿þ¾îÀÇ ¼¼ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. 2025³â¿¡´Â ¼­ºñ½º ºÐ¾ß°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. ½ÃÀåÀÇ ¼­ºñ½º Á¦°ø¾÷ü´Â ÅëÇÕ ÆÐŰÁö¿Í °³º° Á¦Ç° ¸ðµÎ¿¡¼­ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀüÀÚ ÀÇ·á±â·Ï(EMR)°ú ÀüÀڰǰ­±â·Ï(EHR)°ú °°Àº °í±Þ ¼ÒÇÁÆ®¿þ¾î ¹× Ç÷§Æû¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÀÌ ºÐ¾ßÀÇ È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 1¿ù Medtronic°ú Cardiac Design Labs´Â °øµ¿À¸·Î »õ·Î¿î ÀüÀÚ ·çÇÁ ·¹ÄÚ´õ(ELR) ÆÐÄ¡ÀÎ Padma Rhythms¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ ½ÉÇ÷°üÀÇ °Ç°­ »óŸ¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ´Â ¿ø°Ý ÀÇ·á ¿ëµµÀÇ ¿ä±¸ Áõ°¡, µðÁöÅÐ ÀÎÇÁ¶óÀÇ ±Þ¼ÓÇÑ Áøº¸, ÀÎÅÍ³Ý ¹× ½º¸¶Æ®Æù º¸±Þ·ü Áõ°¡, Çϵå¿þ¾î ¹× ¼ÒÇÁÆ®¿þ¾î ±¸¼º ¿ä¼ÒÀÇ ±Þ¼ÓÇÑ °³¹ß µîÀÌ ºÎ¹® ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó ȯÀÚ, ÁöºÒÀÚ, ÀÇ·á Á¦°ø¾÷ü ¹× ±âŸ ³× °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ÃÖÁ¾ ¿ëµµ ºÐ¾ß¿¡¼­´Â µðÁöÅÐ Ä¡·á ¹× ¿ø°Ý ÀÇ·á¿Í °°Àº Çõ½ÅÀûÀÎ ±â¼úÀÇ ±Þ¼ÓÇÑ µµÀÔÀ¸·Î °ø±ÞÀÚ ºÐ¾ß°¡ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â °³ÀÎÈ­µÈ Ä¡·á °èȹ, ¿ø°Ý Áø´Ü ¹× ÀüÅëÀûÀÎ Ä¡·á¸¦ ¹þ¾î³­ Áõ°Å ±â¹Ý Ä¡·á¸¦ Á¦°øÇϱâ À§ÇØ µðÁöÅÐ ¼Ö·ç¼ÇÀ» ºü¸£°Ô µµÀÔÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ µµ±¸¸¦ ÅëÇÕÇÔÀ¸·Î½á ÀÇ·á Á¦°ø¾÷ü´Â º¸´Ù °³ÀÎÈ­µÇ°í »ç¿ëÇϱ⠽¬¿î ÀǷḦ Á¦°øÇÒ ¼ö ÀÖ¾î ±Ã±ØÀûÀ¸·Î ȯÀÚÀÇ °á°ú °³¼±À¸·Î À̾îÁý´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀº ½ÉÇ÷°ü ½ÃÀå¿¡¼­ µðÁöÅÐ °Ç°­ÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ȯÀÚÀÇ °á°ú¿Í °Ç°­ °ü¸®ÀÇ È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù.

½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå - Áö¸®Àû ÅëÂû

ºÏ¹Ì´Â µðÁöÅÐ ÀÎÇÁ¶ó¸¦ Áö¿øÇÏ´Â °Ç°­ °ü¸® IT ÁöÃâ Áõ°¡, ±â¼ú Áøº¸ ¹× Á¤ºÎ Áö¿ø ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÅëÇØ 2025³â¿¡´Â ½ÉÇ÷°ü ¾÷°è ÀüüÀÇ µðÁöÅÐ °Ç°­À» Áö¹èÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 5¿ù ¹Ì±¹ ½ÉÀ庴ÇÐȸ´Â µðÁöÅÐ °Ç°­ ÀÌ´Ï¼ÅÆ¼ºê¸¦ Áö¿øÇϰí ÃֽаúÇÐÀû ¹ß°ßÀ» ¹ßÇ¥Çϱâ À§ÇÑ ¿øÄ¢ ÁöħÀ» ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ ºÏ¹Ì¿¡¼­´Â ¿ø°Ý ÀÇ·á Ç÷§Æû°ú ¿¬°èµÈ °Ç°­ °ü¸®¸¦ À§ÇÑ ¿þ¾î·¯ºí µð¹ÙÀ̽ºÀÇ µµÀÔÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕ ½Ã½ºÅÛÀº Á¶±â °³ÀÔÀ» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ȯÀÚÀÇ °á°ú¿Í Áö¿ª»çȸ ÀüüÀÇ °Ç°­À» °³¼±Çϴµ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ CAGRÀÌ ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ª ½ÃÀåÀº ÀÌ Áö¿ª¿¡¼­ m-Health Ç÷§ÆûÀ» äÅÃÇÏ°í °Ç°­ °ü¸® ÁöÃâÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °Ô´Ù°¡ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ »ê¾÷¼ºÀåÀº °Ç°­ °ü¸®¿¡ ´ëÇÑ Á¤ºÎ ÁöÃâÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ ºÐ¾ßÀÇ ±â¼úÀû Áøº¸¿¡ ÀÇÇØ °ßÀ뵃 °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Âü¿© Áõ°¡¿Í Æ´»õ ±â¾÷ÀÌ º¥Ã³ÀÇ ÃâÇöÀÌ µðÁöÅÐ ¾Û°ú Ç÷§ÆûÀÇ Áö¿ª äÅÃÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå - °æÀï ±¸µµ:

½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀåÀº °æÀïÀÌ Ä¡¿­ÇÏ°í ºü¸£°Ô ÁøÈ­Çϰí ÀÖÀ¸¸ç, ÁÖ¿ä ±â¾÷µéÀº AI, IoT, ¿þ¾î·¯ºí µð¹ÙÀ̽º, Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû µîÀÇ Ã·´Ü ±â¼úÀ» »ç¿ëÇÏ¿© ½ÉÇ÷°ü Áúȯ °ü¸®¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. Apple, Inc., Ultrasonics Limited, Orange Business, Siemens Healthineers AG, Epic Systems CorporationÀº ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ, ½º¸¶Æ® Áø´Ü ¹× ¿ø°Ý ½ÉÀ庴 ¼Ö·ç¼ÇÀÇ ¼±±¸ÀÚÀÌÀÚ ½ÃÀå Çõ½ÅÀ» À̲ø°í ÀÖ½À´Ï´Ù. iRhythm Technologies, AliveCor µî ½Å±Ô ±â¾÷°ú Çï½ºÅØ ±â¾÷µµ AI¸¦ Ȱ¿ëÇÑ ECG ¸ð´ÏÅ͸µ°ú ºÎÁ¤¸Æ °ËÃâ Á¦°øÀ¸·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. Àü·«Àû Á¦ÈÞ, Á¦Ç° Ãâ½Ã, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀÌ °æÀïÀ» ¹Ð¾î ¿Ã¸®´Â ¹Ý¸é, µðÁöÅÐ Ä¡·áÁ¦¿Í ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ¾÷°è ÆÇµµ°¡ ÀçÆíµÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå °³¿ä

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ÃßÁ¤ ¿¬µµ

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ºÐ¼®
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå ½ÉÇ÷°ü µðÁöÅÐ ÇコÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ½ÃÀå Àü¸Á µ¿Çâ

Á¦4Àå ½ÉÇ÷°ü µðÁöÅÐ ÇコÀÇ ¾÷°è Á¶»ç

  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ¼ºÀå Àü¸Á ¸ÊÇÎ
  • ±ÔÁ¦ Ʋ ºÐ¼®

Á¦5Àå ½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

  • COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ
  • ·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ÀüÀïÀÇ ¿µÇâ
  • Áßµ¿ ºÐÀïÀÇ ¿µÇâ

Á¦6Àå ½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå »óȲ

  • ½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
  • ÁÖ¿ä Á¦Á¶¾÷üº° ºÐ¼® µ¥ÀÌÅÍ
    • ±âÁ¸ ±â¾÷ÀÇ ºÐ¼®
    • ½Å±Ô ±â¾÷ÀÇ ºÐ¼®

Á¦7Àå ½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå - ±¸¼º¿ä¼Òº°

  • °³¿ä
    • ±¸¼º¿ä¼Òº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ¼ÒÇÁÆ®¿þ¾î
    • ¼­ºñ½º
    • Çϵå¿þ¾î

Á¦8Àå ½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå - ÃÖÁ¾ ¿ëµµº°

  • °³¿ä
    • ÃÖÁ¾ ¿ëµµº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ȯÀÚ
    • Payers
    • °ø±ÞÀÚ
    • ±âŸ

Á¦9Àå ½ÉÇ÷°ü µðÁöÅÐ Çコ ½ÃÀå - Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
    • °³¿ä
    • ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • °³¿ä
    • À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • ·¯½Ã¾Æ
    • Æú¶õµå
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • °³¿ä
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ű¹
    • Çʸ®ÇÉ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • °³¿ä
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • °³¿ä
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • Æ¢¸£Å°¿¹
    • ¾ËÁ¦¸®
    • ÀÌÁýÆ®
    • ±âŸ

Á¦10Àå ÁÖ¿ä º¥´õ ºÐ¼® - ½ÉÇ÷°ü µðÁöÅÐ Çコ ¾÷°è

  • °æÀï º¥Ä¡¸¶Å·
    • °æÀï ´ë½Ãº¸µå
    • °æÀï Æ÷Áö¼Å´×
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Apple, Inc.
    • Ultrasonics Limited
    • Orange Business
    • Siemens Healthineers AG
    • Epic Systems Corporation
    • NXGN Management, LLC.
    • GE HealthCare
    • Viz.ai, Inc.
    • CardiAI
    • Ultrasonics Limited
    • Cardiologs
    • UltraSight
    • HeartVista Inc.(Vista.ai)
    • RSIP Vision
    • Cleerly, Inc.
    • ±âŸ

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§Àû Àü¸Á

SHW 25.09.26

Digital Health For Cardiovascular Market size was valued at US$ 42,624.29 Million in 2024, expanding at a CAGR of 22.50% from 2025 to 2032.

The Digital Health for Cardiovascular Market is a subset of healthcare that employs digital technologies such as mobile health apps, wearable devices, telemedicine, remote monitoring tools, artificial intelligence (AI), and cloud-based platforms to prevent, diagnose, monitor, and manage cardiovascular diseases. This market includes solutions that enable real-time data collection, remote patient engagement, and personalized cardiovascular care in order to improve patient outcomes, enhance clinical decision-making, and lower healthcare costs. It includes a wide range of products and services designed to treat conditions such as hypertension, arrhythmias, heart failure, and coronary artery disease using technology-driven interventions.

Digital Health For Cardiovascular Market- Market Dynamics

Surge In Cardiovascular Diseases Fuels Growth of Digital Health For Cardiovascular Market

The rising global prevalence of cardiovascular disease is expected to drive the growth of the Digital Health For Cardiovascular Market in the coming years. Cardiovascular diseases (CVDs) are conditions affecting the heart and blood vessels. It is a common term for diseases that harm the heart or blood vessels. Cardiovascular digital solutions help to promote patient autonomy by allowing patients to self-monitor health activities that reduce disease risk factors and encourage adherence to these lifestyle changes. The use of these solutions reduced the morbidity and mortality from cardiovascular diseases. As a result, the rise in cardiovascular disease cases drives up demand for cardiovascular digital solutions. For instance, in March 2024, according to data published by the Office for Health Improvement and Disparities, a UK-based government department, there were just over 1,862,500 people (3%) with a GP diagnosis of coronary heart disease in England. As a result, the global prevalence of cardiovascular disease is driving the Digital Health For Cardiovascular Market.

Digital Health For Cardiovascular Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 22.50% over the forecast period (2025-2032)

Based on Component segmentation, in 2025, the services segment will have the largest market share.

The provider segment held a significant market share in the end-use segment.

On the basis of region, North America generated the most revenue in 2025.

Digital Health For Cardiovascular Market- Segmentation Analysis:

The Global Digital Health For Cardiovascular Market is segmented on the basis of Component, End-use, and Region.

The market is divided into three categories based on Component: Software, Services, and Hardware. In 2025, the services segment will account for the largest market share. Market service providers offer their solutions in both integrated packages and individual products. The growing demand for advanced software and platforms, such as Electronic Medical Records (EMRs) and Electronic Health Records (EHRs), is propelling segment expansion. For instance, in January 2024, Medtronic and Cardiac Design Labs collaborated to introduce Padma Rhythms, a new Electronic Loop Recorder (ELR) patch. Furthermore, the growing need for telehealth applications to monitor cardiovascular health in real time, rapid advancements in digital infrastructure, rising internet and smartphone penetration, and rapid development of hardware and software components are all expected to drive segment growth.

The market is divided into four categories based on End-use: Patients, Payers, Providers, and Others. The provider segment accounted for a significant market share in the end-use segment, owing to the rapid adoption of innovative technologies such as digital therapeutics and telemedicine. Healthcare providers are rapidly adopting digital solutions to deliver personalized treatment plans, remote consultations, and evidence-based therapies that go beyond traditional care. By incorporating digital tools, providers can provide more personalized and accessible care, which ultimately leads to better patient outcomes. These factors contribute to the growth of digital health in the cardiovascular market, improving patient outcomes and healthcare efficiency.

Digital Health For Cardiovascular Market- Geographical Insights

North America will dominate the overall digital health for the cardiovascular industry in 2025, owing to increased healthcare IT expenditure to support digital infrastructure, technological advancements, and supportive government initiatives. For instance, in May 2022, the American College of Cardiology published principles guidelines to support digital health initiatives and announce the most recent scientific discoveries. Furthermore, the population in North America is increasingly adopting wearable devices for health management in conjunction with telemedicine platforms. These integrated systems play a critical role in improving patient outcomes and overall community health by allowing for early intervention.

Asia Pacific is expected to have the fastest CAGR over the forecast period. The regional market is expected to grow due to increased mHealth platform adoption and healthcare expenditure in the region. Furthermore, the Asia Pacific region's industry growth is expected to be driven by technological advancements in the field as government spending on healthcare increases. The growing involvement of key market players, as well as the emergence of niche entrepreneurial ventures in Asia Pacific, have boosted regional adoption of digital apps and platforms.

Digital Health For Cardiovascular Market- Competitive Landscape:

The digital health for cardiovascular market is highly competitive and rapidly evolving, with key players using advanced technologies such as AI, IoT, wearable devices, and cloud-based platforms to improve cardiovascular disease management. Apple, Inc., Ultrasonics Limited, Orange Business, Siemens Healthineers AG, and Epic Systems Corporation are pioneers in remote patient monitoring, smart diagnostics, and telecardiology solutions, driving market innovation. Startups and health-tech companies such as iRhythm Technologies and AliveCor are also gaining traction for providing AI-powered ECG monitoring and arrhythmia detection. Strategic collaborations, product launches, and regulatory approvals are driving up competition, while increased investments in digital therapeutics and personalised care are reshaping the industry landscape.

Recent Developments:

In March 2024, Wellysis, a Samsung subsidiary, has collaborated with Artella Solutions (ARTELLA) to launch its remote cardiac monitoring service in the United States. This collaboration aims to provide the FDA-cleared S-Patch electrocardiogram monitoring solution from ARTELLA in ten states.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Apple, Inc.
  • Ultrasonics Limited
  • Orange Business
  • Siemens Healthineers AG
  • Epic Systems Corporation
  • NXGN Management, LLC.
  • GE HealthCare
  • Viz.ai, Inc.
  • CardiAI
  • Ultrasonics Limited
  • Cardiologs
  • UltraSight
  • HeartVista Inc. (Vista.ai)
  • RSIP Vision
  • Cleerly, Inc.
  • Others

GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services
  • Hardware

GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Patients
  • Payers
  • Providers
  • Others

GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Digital Health For Cardiovascular Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Digital Health For Cardiovascular Market Snippet by Component
    • 2.1.2. Digital Health For Cardiovascular Market Snippet by End-use
    • 2.1.3. Digital Health For Cardiovascular Market Snippet by Country
    • 2.1.4. Digital Health For Cardiovascular Market Snippet by Region
  • 2.2. Competitive Insights

3. Digital Health For Cardiovascular Key Market Trends

  • 3.1. Digital Health For Cardiovascular Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Digital Health For Cardiovascular Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Digital Health For Cardiovascular Market Opportunities
  • 3.4. Digital Health For Cardiovascular Market Future Trends

4. Digital Health For Cardiovascular Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Digital Health For Cardiovascular Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Digital Health For Cardiovascular Market Landscape

  • 6.1. Digital Health For Cardiovascular Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Digital Health For Cardiovascular Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services
    • 7.1.4. Hardware

8. Digital Health For Cardiovascular Market - By End-use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End-use, 2024 & 2032 (%)
    • 8.1.2. Patients
    • 8.1.3. Payers
    • 8.1.4. Providers
    • 8.1.5. Others

9. Digital Health For Cardiovascular Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Digital Health For Cardiovascular Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Digital Health For Cardiovascular Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.7. UK
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.7.4. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.8. France
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.8.4. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.9. Italy
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.9.4. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.10. Spain
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.10.4. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.11. The Netherlands
      • 9.3.11.1. Overview
      • 9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.11.4. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Overview
      • 9.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.12.4. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.13. Russia
      • 9.3.13.1. Overview
      • 9.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.13.4. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Digital Health For Cardiovascular Key Manufacturers in Asia Pacific
    • 9.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.4.5. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.6. China
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.6.4. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.7.4. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.11. Indonesia
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.12. Thailand
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.5. Latin America (LATAM)
    • 9.5.1. Overview
    • 9.5.2. Digital Health For Cardiovascular Key Manufacturers in Latin America
    • 9.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.5.5. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa (MEA)
    • 9.6.1. Overview
    • 9.6.2. Digital Health For Cardiovascular Key Manufacturers in Middle East and Africa
    • 9.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 9.6.5. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.7. UAE
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. UAE Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.7.4. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Digital Health For Cardiovascular Industry

  • 10.1. Competitive Benchmarking
    • 10.1.1. Competitive Dashboard
    • 10.1.2. Competitive Positioning
  • 10.2. Company Profiles
    • 10.2.1. Apple, Inc.
    • 10.2.2. Ultrasonics Limited
    • 10.2.3. Orange Business
    • 10.2.4. Siemens Healthineers AG
    • 10.2.5. Epic Systems Corporation
    • 10.2.6. NXGN Management, LLC.
    • 10.2.7. GE HealthCare
    • 10.2.8. Viz.ai, Inc.
    • 10.2.9. CardiAI
    • 10.2.10. Ultrasonics Limited
    • 10.2.11. Cardiologs
    • 10.2.12. UltraSight
    • 10.2.13. HeartVista Inc. (Vista.ai)
    • 10.2.14. RSIP Vision
    • 10.2.15. Cleerly, Inc.
    • 10.2.16. Others

11. 360 Degree AnalystView

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦